CWA Asset Management Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
BTCPP
AAMU
AIM
AV
CWA Asset Management Group's AZN Position: Q2 2026 in Review
CWA Asset Management Group increased its AstraZeneca (AZN) stake by 6.7% in Q2 2026, buying an estimated $17.7K and bringing the position to 1,495 shares worth $283K. The position accounts for 0.01% of the portfolio, ranked #608.
CWA Asset Management Group first reported a position in AZN in Q2 2019 and has held it in 20 quarters since. The position peaked at $499K in Q4 2019. 534 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- CWA Asset Management Group held 1,495 shares of AstraZeneca worth $283K as of Q2 2026.
- CWA Asset Management Group bought 94 AstraZeneca shares in Q2 2026, an estimated $17.7K.
- AstraZeneca made up 0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #608 holding.
- CWA Asset Management Group first reported a position in AstraZeneca in Q2 2019 and has held it in 20 quarters since.
- CWA Asset Management Group's AstraZeneca position peaked at $499K in Q4 2019.
- 534 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.